Investor Alert: Galectin Therapeutics Inc. (NASDAQ:GALT) Under Investigation over Potential Violations of Federal Securities Laws
An investigation on behalf of investors of Galectin Therapeutics Inc. (NASDAQ:GALT) shares over potential securities laws violations by Galectin Therapeutics Inc. and certain of its directors and officers in connection certain financial statements was announced.
View full press release